Premium
The use of calcipotriol in HIV‐related psoriasis
Author(s) -
GRAY J.D.,
BOTTOMLEY W.,
LAYTON A.M.,
COTTERILL J.A.,
MONTEIRO E.
Publication year - 1992
Publication title -
clinical and experimental dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.587
H-Index - 78
eISSN - 1365-2230
pISSN - 0307-6938
DOI - 10.1111/j.1365-2230.1992.tb00226.x
Subject(s) - calcipotriol , psoriasis , medicine , dermatology , human immunodeficiency virus (hiv) , vitamin d and neurology , immunology
Summary We report the case of a 28‐year‐old homosexual man with advanced HIV disease (CDC classification group IV A) who developed erythrodermic psoriasis which responded to calcipotriol, a topical vitamin D analogue. We believe this to be the first reported case of HIV‐related psoriasis responsive to this form of treatment. Systemic therapy for HIV‐related psoriasis is limited because of immunosuppressive effects. We suggest that calcipotriol may prove to be a useful therapeutic option in these patients.